Silencing the Androgen Receptor: New Skills for Antiandrogen Oligonucleotide Skin and Hair Therapy

The document discussed the role of androgens in regulating hair growth and their contribution to androgenetic alopecia, a condition affecting over 50% of men by age 50 and women over 60. It highlighted that androgens, particularly testosterone and dihydrotestosterone, inhibit hair follicle activity by shortening the anagen phase and inducing catagen, leading to follicle miniaturization and hair thinning. The study suggested that targeting androgen receptors with antiandrogen oligonucleotides could be a promising therapeutic approach, as current treatments were not fully effective and had potential side effects.